GlassScriptPhysician profile
Jake Foote
NPI 1518582048
$9,720.82
in general payments reported to CMS, 2019-2025
12 companies · $4,053 in 2025
The $4,053 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.69 · 2021: $2,878 · 2022: $1,218 · 2023: $526 · 2024: $1,034 · 2025: $4,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,529 · Travel and Lodging: $2,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,528.89 |
| Travel and Lodging | $2,083.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,409.64 | 2021-2022 | |
| Stryker Corporation | $2,107.70 | 2020-2025 | Mako, Insignia, Ortholoc 3di |
| Smith+Nephew, INC. | $1,954.89 | 2025 | Evos, Evos Mini, Real Intelligence |
| Medical Device Business Services, INC. | $1,326.53 | 2021 | |
| Depuy Synthes Sales INC. | $637.06 | 2021-2025 | Na, Inhance, Actis |
| Zimmer Biomet Holdings, INC. | $451.80 | 2021-2025 | Persona |
| Axogen | $317.64 | 2022-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Convatec INC. | $168.65 | 2025 | |
| Illuminoss Medical, INC. | $168.02 | 2024 | |
| Aroa Biosurgery Incorporated | $138.45 | 2024 | |
| Encore Medical, LP | $27.01 | 2023 | Djo Surgical |
| Boston Scientific Corporation | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Foote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.